Intertwined Structured and Unstructured Regions of exRAGE Identified by Monitoring Hydrogen-Deuterium Exchange

Journal of Molecular Biology

Volumn 403, Issue 1, 2010, Pages 52-65

  Kupniewska Kozak, Anna ^a   Gospodarska, Emilia ^a   Dadlez, Michal ^a,b  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

Hydrogen deuterium exchange; Mass spectrometry; Protein structure; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; PEPSIN A; DEUTERIUM; HYDROGEN; MITOGEN ACTIVATED PROTEIN KINASE; MOK PROTEIN, HUMAN; TUMOR ANTIGEN;

ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEUTERIUM HYDROGEN EXCHANGE; EXTRACELLULAR DOMAIN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SOLVENT EFFECT; X RAY CRYSTALLOGRAPHY; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; HUMAN; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; DEUTERIUM; HUMANS; HYDROGEN; MASS SPECTROMETRY; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY;

EID: 77957258577     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.08.027     Document Type: Article

References (41)

1. Schmidt A.M., Vianna M., Gerlach M., Brett J., Ryan J., Kao J., et al. Isolation and characterisation of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface. J. Biol. Chem. 1992, 267:14987-14997.
2. Hori O., Yan S.D., Ogawa S., Kuwabara K., Matsumoto M., Stern D., Schmidt A.M. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus. Nephrol. Dial. Transplant. 1996, 11:13-16.
3. Arancio O., Zhang H.P., Chen X., Lin C., Trinchese F., Puzzo D., et al. RAGE potentiates Aβ-induced perturbation of neuronal function in transgenic mice. EMBO J. 2004, 23:4096-4104.
4. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., et al. RAGE and Aβ peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
5. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 7:889-901.
6. Arumugam T., Simeone D.M., Schmidt A.M., Logsdon C.D. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J. Biol. Chem. 2004, 7:5059-5065.
7. Sorci G., Riuzzi F., Agneletti A.L., Marchetti C., Donato R. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol. Cell. Biol. 2003, 14:4870-4881.
8. Miyata T., Hori O., Zhang J., Yan S.D., Ferran L., Iida Y., Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J. Clin. Invest. 1996, 98:1088-1094.
9. Yan S.D., Zhu H.J., Zhu A.P., Golabek A., Du H., Roher A., et al. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 2000, 6:643-651.
10. Sousa M.M., Yan S.D., Stern D., Saraiva M.J. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor jB (NF-jB) activation. Lab. Invest. 2000, 80:1101-1110.
11. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
12. Chen X., Walker D.G., Schmidt A.M., Arancio O., Lue L.F., Yan S.D. RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease. Curr. Mol. Med. 2007, 7:735-742.
13. Deane R., Wu Z., Zlokovic B.V. RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke 2004, 35:2628-2631.
14. Muhammad S., Barakat W., Stoyanov S., Murikinati S., Yang H., Tracey K.J., et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 2008, 28:12023-12031.
15. Qiu J., Nishimura M., Wang Y., Sims J.R., Qiu S., Savitz S.I., et al. Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28:927-938.
16. Yan S.F., Lu J., Xu L., Zou Y.S., Tongers J., Kisiel W., et al. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 2000, 6:643-651.
17. Toth C., Martinez J., Zochodne D.W. RAGE, diabetes, and the nervous system. Curr. Mol. Med. 2007, 8:766-776.
18. Yamamoto H., Watanabe T., Yamamoto Y., Yonekura H., Munesue S., Harashima A., et al. RAGE in diabetic nephropathy. Curr. Mol. Med. 2007, 8:752-757.
19. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 2001, 108:949-955.
20. Clynes R., Moser B., Yan S.F., Ramasamy R., Herold K., Schmidt A.M. Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr. Mol. Med. 2007, 8:743-751.
21. Logsdon C.D., Fuentes M.K., Huang E.H., Arumugam T. RAGE and RAGE ligands in cancer. Curr. Mol. Med. 2007, 8:777-789.
22. Li J., Schmidt A.M. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem. 1997, 26:16498-16506.
23. Tanaka N., Yonekura H., Yamagishi S., Fujimori H., Yamamoto Y., Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 2000, 33:25781-25790.
24. Sturchler E., Galichet A., Weibel M., Leclerc E., Heizmann C.W. Site-specific blockade of RAGE-Vd prevents amyloid-β oligomer neurotoxicity. J. Neurosci. 2008, 28:5149-5158.
25. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., et al. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992, 267:14998-15004.
26. Bork P., Holm L., Sander C. The immunoglobulin fold: structural classification, sequence patterns and common core. J. Mol. Biol. 1994, 242:309-320.
27. Xie J., Reverdatto S., Frolov A., Hoffmann R., Burz D.S., Shekhtman A. A structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J. Biol. Chem. 2008, 283:27255-27269.
28. Dattilo B.M., Fritz G., Leclerc E., Kooi C.W., Heizmann C.W., Chazin W.J. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 2007, 46:6957-6970.
29. Matsumoto S., Yoshida T., Murata H., Harada S., Fujita N., Nakamura S., et al. Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction. Biochemistry 2008, 47:12299-12311.
30. Zhang Z., Smith D.L. Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci. 1993, 2:522-531.
31. Engen J.R., Smith D.L. Investigating the higher order structure of proteins. Hydrogen exchange, proteolytic fragmentation, and mass spectrometry. Methods Mol. Biol. 2000, 146:95-112.
32. Maier C.S., Deinzer M.L. Protein conformations, interactions, and H/D exchange. Methods Enzymol. 2005, 402:312-360.
33. Englander S.W. Hydrogen exchange and mass spectrometry: a historical perspective. J. Am. Chem. Soc. 2006, 17:1481-1489.
34. Ostendorp T., Leclerc E., Galichet A., Koch M., Demling N., Weigle B., et al. Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 2007, 26:3868-3878.
35. Xie J., Burz D.S., He W., Bronstein I.B., Lednev I., Shekhtman A. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J. Biol. Chem. 2007, 282:4218-4231.
36. Chung C.M., Chiu J.D., Connors L.H., Gursky O., Lim A., Dykstra A.B., et al. Thermodynamic stability of a kappaI immunoglobulin light chain: relevance to multiple myeloma. Biophys. J. 2005, 88:4232-4242.
37. Bazoni F., Alejos E., Beutler B. Chimeric tumor necrosis factor receptors with constitutive signaling activity. Proc. Natl Acad. Sci. USA 1995, 92:5376-5380.
38. Hu X., Yagi Y., Tanji T., Zhou S., Ip Y.T. Multimerisation and interaction of Toll and Spatzle in Drosophila. Proc. Natl Acad. Sci. USA 2004, 101:9369-9374.
39. de Bouteiller O., Merck E., Hasan U.A., Hubac S., Benguigui B., Trinchieri G., et al. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerisation and an acidic pH. J. Biol. Chem. 2005, 280:38133-38145.
40. Bakun M., Kaczmarski J., Poznanski J., Rubel T., Rozga M., Malinowska A., et al. An integrated LC-ESI-MS platform for quantitation of serum peptide ladders. Application for colon carcinoma study. Proteomics Clin. Appl. 2009, 3:932-946.
41. Rutkowska-Wlodarczyk I., Stepinski J., Dadlez M., Darzynkiewicz E., Stolarski R., Niedzwiecka A. Structural changes of eIF4E upon binding to the mRNA 5' monomethyloguanosine and trimethyloguanosine cap. Biochemistry 2008, 47:2710-2720.